Cargando…
Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in Lung Adenocarcinoma
Lung cancer is one of the deadliest cancers worldwide, including in Taiwan. The poor prognosis of the advanced lung cancer lies in delayed diagnosis and non-druggable targets. It is worth paying more attention to these ongoing issues. Public databases and an in-house cohort were used for validation....
Autores principales: | Chang, Chao-Yuan, Huang, Yung-Chi, Chiang, Hung-Hsing, Wu, Yu-Yuan, Wu, Kuan-Li, Chang, Yung-Yun, Liu, Lian-Xiu, Tsai, Ying-Ming, Hsu, Ya-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820746/ https://www.ncbi.nlm.nih.gov/pubmed/36613882 http://dx.doi.org/10.3390/ijms24010431 |
Ejemplares similares
-
The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy
por: Lee, Hsiao-Chen, et al.
Publicado: (2022) -
Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma
por: Lee, Hsiao-Chen, et al.
Publicado: (2022) -
Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor 4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune Microenvironment Reprogramming
por: Wu, Kuan-Li, et al.
Publicado: (2022) -
The Tumorigenic Effect of the High Expression of Ladinin-1 in Lung Adenocarcinoma and Its Potential as a Therapeutic Target
por: Hu, Lei, et al.
Publicado: (2023) -
Ubiquitin Conjugating Enzyme E2 H (UBE2H) Is Linked to Poor Outcomes and Metastasis in Lung Adenocarcinoma
por: Yen, Meng-Chi, et al.
Publicado: (2021)